A Circulating Tumor Cell-RNA Assay for Assessment of Androgen Receptor Signaling Inhibitor Sensitivity in Metastatic Castration-Resistant Prostate Cancer

Rationale: Our objective was to develop a circulating tumor cell (CTC)-RNA assay for characterizing clinically relevant RNA signatures for the assessment of androgen receptor signaling inhibitor (ARSI) sensitivity in metastatic castration-resistant prostate cancer (mCRPC) patients. Methods: We devel...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Theranostics
Main Authors: Jan, Yu Jen, Yoon, Junhee, Chen, Jie-Fu, Teng, Pai-Chi, Yao, Nu, Cheng, Shirley, Lozano, Amber, Chu, Gina C.Y., Chung, Howard, Lu, Yi-Tsung, Chen, Pin-Jung, Wang, Jasmine J., Lee, Yi-Te, Kim, Minhyung, Zhu, Yazhen, Knudsen, Beatrice S., Feng, Felix Y., Garraway, Isla P., Gao, Allen C., Chung, Leland W. K., Freeman, Michael R., You, Sungyong, Tseng, Hsian-Rong, Posadas, Edwin M.
Formato: Artigo
Idioma:Inglês
Publicado em: Ivyspring International Publisher 2019
Assuntos:
Research Paper
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6568173/
https://ncbi.nlm.nih.gov/pubmed/31244925
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.7150/thno.34485
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados